Skip to content

Intestinal Inflammatory and Metabolic Responses to a High Fat Meal and Plant Polyphenol Blend

A Randomized Placebo-controlled Cross-over Design Study Investigating the Effects of a Plant Polyphenol Blend on the Intestinal Inflammatory and Metabolic Responses to a High Fat Meal in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03309982
Enrollment
27
Registered
2017-10-16
Start date
2017-10-16
Completion date
2018-03-27
Last updated
2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anthocyanins

Brief summary

This study will investigate the beneficial effects of supplementation with a plant polyphenol blend rich in anthocyanins on parameters of inflammation and metabolic responses following a challenge with a high-fat (HF) meal. The investigators will use a randomized crossover study to investigate the effects of: 1) placebo (control); 2) plant polyphenol blend rich in anthocyanins; on systemic inflammatory markers (endotoxemia, cytokines, NF-κB), glucose and lipid metabolic responses following consumption of a high-fat (HF) meal in healthy subjects. The high-fat meal (320 g) consists of English muffin bread, sausage, egg and cheese, obtained from US market and completed with palm fat. The total energy content of the high-fat meal is 1,026 Kcal with 70.5 g of fat (29.8 g of saturated fat), 270 mg of cholesterol, 65 g carbohydrate, 5.2 g sugar, and 33 g protein with a total of 62% energy originated from fat, 25% from carbohydrates and 13% from protein. The high-fat meal will be standard and it will not be adjusted for large and small participants.

Interventions

DIETARY_SUPPLEMENTPlant polyphenol blend

A powder product that will be mixed into a drink and consumed immediately prior to eating a high-fat meal

OTHERPlacebo

A powder product that will be mixed into a drink and consumed immediately prior to eating a high-fat meal

Sponsors

Pharmanex
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

A randomized placebo-controlled cross-over design study

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy subjects who, in the opinion of the investigator, are free of any medical conditions that might affect study measures. 2. Males and females 3. Age between 18 - 35 years inclusive 4. Subjects with BMI of 22 - 29.9 kg/m2 5. Subjects who agree to discontinue the use of pre- and probiotic and/or polyphenol supplements from 4 weeks prior to the first and through the last study visit 6. Subjects who agree to discontinue foods containing anthocyanins (such as blueberries, blackberries, bilberries, cherries, grapes, grape juice, pomegranate, raspberries, huckleberries, strawberries, and red wine) for at least 1 week prior to each visit. 7. Subjects with no known allergies to study product or components (bilberries, black currants, rice) 8. Subjects willing to completely consume high-fat meal and assigned study product 9. Subjects willing to consume a similar, low fat/low flavonoid \\dinner the evening before each high-fat meal visit 10. Subjects have given voluntary, written, informed consent to participate in the study

Exclusion criteria

1. Age \< 18 or \> 35 years 2. BMI \< 22 or \> 29.9 kg/m2 3. Vegetarian or other dietary restrictions that would not allow the subject to consume the highfat meal 4. Regularly participates in endurance exercise activities (e.g. marathon running, triathlons) 5. Uncontrolled hypertension defined as diastolic blood pressure ≥ 95 mmHg or systolic blood pressure ≥ 160 mmHg 6. Screening serum triglycerides \> 150 mg/dL 7. Screening fasting blood glucose \< 50 mg/dL or \> 100 mg/dL 8. Current smoker or use of tobacco products within the past year 9. Individuals who binge drink (alcohol intake ≥ 5 alcoholic drinks for males or ≥4 alcoholic drinks for females on the same occasion (i.e., at the same time or within a couple of hours of each other) 10. Substance abuse or dependence within the prior 60 days. 11. Daily use of anti-inflammatory medications including NSAIDs and aspirin in the last 4 weeks 12. Use of laxative medications or other products that promote colon cleansing in the last 4 weeks 13. History of restricted diets or use of herbal supplements or medications that interfere with insulin metabolism in the last 4 weeks 14. History of stroke, hepatic, kidney, thyroid disease or cancer 15. History of immune related disorders or Raynaud's disease 16. Current clinically significant depression, anxiety or other psychiatric condition 17. History of malabsorption or GI tract disorders 18. History of GI surgeries (i.e. lapband, gastric bypass, etc.) 19. Diarrhea or oral antibiotic intake within the last 4 weeks 20. Weight change (\> 5%) in the last 8 weeks 21. Subject with known history of eating disorders such as bulimia, anorexia, or muscle dysmorphia 22. Allergy or sensitivity to the study product or components of the high-fat meal 23. Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in plasma endotoxin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure endotoxin in plasma

Secondary

MeasureTime frameDescription
Change from baseline in plasma IL-6 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure IL-6 in plasma
Change from baseline in plasma GLP-1 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure GLP-1 in plasma
Change from baseline in plasma GLP-2 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure GLP-2 in plasma
Change from baseline in plasma GIP at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure GIP in plasma
Change from baseline in plasma adiponectin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure adiponectin in plasma
Change from baseline in plasma leptin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure leptin in plasma
Change from baseline in plasma ghrelin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure ghrelin in plasma
Change from baseline in plasma triglycerides at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure triglycerides in plasma
Change from baseline in plasma total cholesterol at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure total cholesterol in plasma
Change from baseline in plasma HDL at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure HDL in plasma
Change from baseline in PBMC TNFa at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure TNFa in PBMC
Change from baseline in PBMC NF-kB at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure NF-kB in PBMC
Change from baseline in plasma LDL at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure LDL in plasma
Change from baseline in plasma insulin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure insulin in plasma
Change from baseline in plasma total polyphenols at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure total polyphenols in plasma
Change from baseline in plasma total anthocyanidins at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure total anthycyanidins in plasma
Change from baseline in plasma total catechins at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure total catechins in plasma
Change from baseline in plasma glucose at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure glucose in plasma
Change from baseline in PBMC IL-8 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure IL-8 in PBMC
Change from baseline in PBMC IL-10 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure IL-10 in PBMC
Change from baseline in PBMC IL-1β at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure IL-1β in PBMC
Change from baseline in PBMC IL-12p70 at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure IL-12p70 in PBMC
Change from baseline in fingerstick triglycerides at 15 minutes post high-fat meal consumptionBaseline, and 15 minutes post high-fat meal consumptionblood sample collected by fingerstick to measure triglycerides
Change from baseline in fingerstick total cholesterol at 15 minutes post high-fat meal consumptionBaseline, and 15 minutes post high-fat meal consumptionblood sample collected by fingerstick to measure total cholesterol
Change from baseline in fingerstick HDL at 15 minutes post high-fat meal consumptionBaseline, and 15 minutes post high-fat meal consumptionblood sample collected by fingerstick to measure HDL
Change from baseline in fingerstick LDL at 15 minutes post high-fat meal consumptionBaseline, and 15 minutes post high-fat meal consumptionblood sample collected by fingerstick to measure LDL
Change from baseline in fingerstick glucose at 15 minutes post high-fat meal consumptionBaseline, and 15 minutes post high-fat meal consumptionblood sample collected by fingerstick to measure glucose
Change from baseline in plasma zonulin at 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionBaseline, 0.5 hr, 1 hr, 2hrs, 3hrs, and 5hrs post high-fat meal consumptionblood sample collected by venipuncture to measure zonulin in plasma

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026